JP2009515827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009515827A5 JP2009515827A5 JP2008536134A JP2008536134A JP2009515827A5 JP 2009515827 A5 JP2009515827 A5 JP 2009515827A5 JP 2008536134 A JP2008536134 A JP 2008536134A JP 2008536134 A JP2008536134 A JP 2008536134A JP 2009515827 A5 JP2009515827 A5 JP 2009515827A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- nucleic acid
- ramp
- amino acid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0521139.6A GB0521139D0 (en) | 2005-10-18 | 2005-10-18 | Therapeutic agent |
| PCT/GB2006/050338 WO2007045927A2 (en) | 2005-10-18 | 2006-10-18 | Therapeutic agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012190219A Division JP2012246309A (ja) | 2005-10-18 | 2012-08-30 | 治療薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009515827A JP2009515827A (ja) | 2009-04-16 |
| JP2009515827A5 true JP2009515827A5 (enExample) | 2011-06-02 |
Family
ID=35451928
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008536134A Pending JP2009515827A (ja) | 2005-10-18 | 2006-10-18 | 治療薬 |
| JP2012190219A Pending JP2012246309A (ja) | 2005-10-18 | 2012-08-30 | 治療薬 |
| JP2014193911A Pending JP2015003920A (ja) | 2005-10-18 | 2014-09-24 | 治療薬 |
| JP2015133603A Pending JP2015178534A (ja) | 2005-10-18 | 2015-07-02 | 治療薬 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012190219A Pending JP2012246309A (ja) | 2005-10-18 | 2012-08-30 | 治療薬 |
| JP2014193911A Pending JP2015003920A (ja) | 2005-10-18 | 2014-09-24 | 治療薬 |
| JP2015133603A Pending JP2015178534A (ja) | 2005-10-18 | 2015-07-02 | 治療薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20080279857A1 (enExample) |
| EP (2) | EP2402372A3 (enExample) |
| JP (4) | JP2009515827A (enExample) |
| KR (1) | KR20080059449A (enExample) |
| CN (2) | CN101341171A (enExample) |
| AU (1) | AU2006305654B2 (enExample) |
| CA (1) | CA2624931A1 (enExample) |
| GB (1) | GB0521139D0 (enExample) |
| RU (1) | RU2008119096A (enExample) |
| WO (1) | WO2007045927A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| GB0521139D0 (en) | 2005-10-18 | 2005-11-23 | Univ Sheffield | Therapeutic agent |
| GB0708002D0 (en) * | 2007-04-25 | 2007-06-06 | Univ Sheffield | Antibodies |
| CN110372795A (zh) | 2007-08-02 | 2019-10-25 | 吉利德生物制剂公司 | Lox和loxl2抑制剂及其应用 |
| JP5099856B2 (ja) | 2007-11-26 | 2012-12-19 | 独立行政法人科学技術振興機構 | 代謝症候群の治療もしくは予防剤、検査方法、検査薬、及び代謝症候群の治療薬の候補化合物のスクリーニング方法 |
| FR2934597B1 (fr) * | 2008-07-31 | 2013-04-19 | Univ Aix Marseille Ii | Anticorps se liant aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament. |
| JO3382B1 (ar) | 2008-12-23 | 2019-03-13 | Amgen Inc | أجسام مضادة ترتبط مع مستقبل cgrp بشري |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| RU2012110585A (ru) | 2009-08-21 | 2013-09-27 | Джилид Байолоджикс, Инк. | Каталичические домены лизилоксидазы и loxl2 |
| RU2015108348A (ru) | 2010-02-04 | 2015-07-20 | Джилид Байолоджикс, Инк. | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения |
| FR2964103B1 (fr) | 2010-08-30 | 2018-11-23 | Universite D'aix-Marseille | Anticorps se liant a l'adrenomedulline et aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament |
| JP5806859B2 (ja) * | 2011-06-08 | 2015-11-10 | ポーラ化成工業株式会社 | スクリーニング方法 |
| EP2589963A1 (en) | 2011-11-04 | 2013-05-08 | Université de Provence (Aix-Marseille 1) | Diagnostic and treatment of an androgen-independent prostate cancer |
| WO2016044224A1 (en) | 2014-09-15 | 2016-03-24 | Amgen Inc. | Bi-specific anti-cgrp receptor/pac1 receptor antigen binding proteins and uses thereof |
| JP6508670B2 (ja) * | 2014-12-26 | 2019-05-08 | 国立大学法人広島大学 | 軟骨変性抑制剤 |
| JOP20200116A1 (ar) | 2015-04-24 | 2017-06-16 | Amgen Inc | طرق لعلاج أو الوقاية من الصداع النصفي |
| CN105420247B (zh) * | 2015-12-09 | 2018-09-07 | 浙江大学 | 水稻不定根控制基因crlr1的应用 |
| AU2017376400A1 (en) * | 2016-12-13 | 2019-06-20 | Novozymes A/S | Methods for treating inflammatory conditions of the lungs |
| CA3075867A1 (en) * | 2017-09-13 | 2019-03-21 | Gene Techno Science Co., Ltd. | Anti-ramp2 antibody |
| BR112020019882A2 (pt) | 2018-04-02 | 2021-01-05 | Amgen Inc. | Composições de erenumabe e seus usos |
| JP2022512860A (ja) * | 2018-11-06 | 2022-02-07 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 白血病幹細胞を根絶することによる急性骨髄性白血病の治療のための方法および医薬組成物 |
| GB202303531D0 (en) * | 2023-03-10 | 2023-04-26 | Fusion Antibodies Plc | Antibodies and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3045153A1 (de) | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| WO1990005144A1 (en) | 1988-11-11 | 1990-05-17 | Medical Research Council | Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| KR970002255B1 (ko) | 1990-06-11 | 1997-02-26 | 넥스스타 파아마슈티컬드, 인크. | 핵산 리간드 |
| AU665190B2 (en) | 1990-07-10 | 1995-12-21 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| CA2124967C (en) | 1991-12-17 | 2008-04-08 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
| EP0656946B2 (en) | 1992-08-21 | 2010-03-31 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| KR100272659B1 (ko) | 1997-06-28 | 2000-12-01 | 김영환 | 반도체 소자의 금속배선 선폭 측정방법 |
| US20030055231A1 (en) | 1998-10-28 | 2003-03-20 | Jian Ni | 12 human secreted proteins |
| EP1283881A2 (de) | 2000-05-26 | 2003-02-19 | Noxxon Pharma AG | Immobilisierte nukleinsäuren und verwendungen davon |
| WO2004050834A2 (en) * | 2002-11-27 | 2004-06-17 | Genpath Pharmaceuticals, Incorporated | GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
| GB0521139D0 (en) | 2005-10-18 | 2005-11-23 | Univ Sheffield | Therapeutic agent |
| GB0708002D0 (en) * | 2007-04-25 | 2007-06-06 | Univ Sheffield | Antibodies |
-
2005
- 2005-10-18 GB GBGB0521139.6A patent/GB0521139D0/en not_active Ceased
-
2006
- 2006-10-18 CN CNA2006800477847A patent/CN101341171A/zh active Pending
- 2006-10-18 CN CN201510206436.0A patent/CN105037551A/zh active Pending
- 2006-10-18 EP EP11162714A patent/EP2402372A3/en not_active Withdrawn
- 2006-10-18 WO PCT/GB2006/050338 patent/WO2007045927A2/en not_active Ceased
- 2006-10-18 US US12/090,635 patent/US20080279857A1/en not_active Abandoned
- 2006-10-18 CA CA002624931A patent/CA2624931A1/en not_active Abandoned
- 2006-10-18 KR KR1020087011686A patent/KR20080059449A/ko not_active Withdrawn
- 2006-10-18 AU AU2006305654A patent/AU2006305654B2/en not_active Ceased
- 2006-10-18 JP JP2008536134A patent/JP2009515827A/ja active Pending
- 2006-10-18 RU RU2008119096/13A patent/RU2008119096A/ru not_active Application Discontinuation
- 2006-10-18 EP EP06794995A patent/EP1945670A2/en not_active Withdrawn
-
2010
- 2010-08-03 US US12/849,536 patent/US8895005B2/en not_active Expired - Fee Related
-
2012
- 2012-08-30 JP JP2012190219A patent/JP2012246309A/ja active Pending
-
2014
- 2014-09-24 JP JP2014193911A patent/JP2015003920A/ja active Pending
- 2014-10-09 US US14/511,099 patent/US9556268B2/en not_active Expired - Fee Related
-
2015
- 2015-07-02 JP JP2015133603A patent/JP2015178534A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9556268B2 (en) | Therapeutic agent | |
| JP2009515827A5 (enExample) | ||
| CN107847595B (zh) | 特异性针对过度磷酸化τ蛋白的抗体及其使用方法 | |
| CN107098970B (zh) | 结合细胞内prl-1多肽或prl-3多肽的抗体 | |
| CN110267985B (zh) | 用于治疗眼科疾病的特异性针对过度磷酸化τ蛋白的抗体 | |
| KR20180064541A (ko) | 항-il-2 항체 및 조성물 및 이의 용도 | |
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| CN112243443A (zh) | 抗trop-2抗体、其抗原结合片段及其医药用途 | |
| CN115298216A (zh) | 抗体或其抗原结合片段、其制备方法及医药用途 | |
| RU2741802C2 (ru) | АНТИТЕЛО К Myl9 | |
| KR20100034720A (ko) | 피에이유에프(ｐａｕｆ) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법 | |
| CN110606892B (zh) | 一种高亲和力高生物活性的lag-3抗体及其应用 | |
| JP2021535078A (ja) | 骨の疾患の治療に用いるためのトランスフェリン受容体２のアンタゴニスト及びアゴニスト | |
| JP7643727B2 (ja) | 抗－ｆｇｆ１９抗体 | |
| JP7564882B2 (ja) | Ａｒｅｇに対する抗体及びその用途 | |
| HK40049006A (en) | Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof | |
| HK40049006B (en) | Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof | |
| HK40036076B (en) | Anti-trop-2 antibody, antigen binding fragment thereof and medical use thereof | |
| HK40036076A (en) | Anti-trop-2 antibody, antigen binding fragment thereof and medical use thereof | |
| HK40005045B (zh) | 用於治疗ror1癌症并抑制转移的抗体和疫苗 | |
| JP2003310276A (ja) | １２１４位チロシンがリン酸化したＫＤＲ／Ｆｌｋ−１に対する情報伝達分子の結合を阻害する物質およびその利用方法 |